Varicose veins may be setting of next turf war

Article

It's quick, safe, and relatively painless, and if interventional radiologists want to own it, they'd better step up quickly: Endovenous laser treatment of varicose veins is poised to take off, according to researchers at Cornell University. A two-year follow-up of 97 treated limbs showed a 6% recurrence rate, compared with 10% or higher recurrence that was reported for surgery, radio-frequency ablation, and transcatheter sclerotherapy.

It's quick, safe, and relatively painless, and if interventional radiologists want to own it, they'd better step up quickly: Endovenous laser treatment of varicose veins is poised to take off, according to researchers at Cornell University. A two-year follow-up of 97 treated limbs showed a 6% recurrence rate, compared with 10% or higher recurrence that was reported for surgery, radio-frequency ablation, and transcatheter sclerotherapy.

The U.S. study was presented at this year's 15th annual International Symposium on Endovascular Therapy. It showed that laser treatment can be performed in an outpatient setting.

"Most of the people qualified to perform this procedure should be interventional radiologists, but over the next couple of years there will be thousands of physicians doing it, including vascular and general surgeons and even dermatologists," said Dr. Robert Min, coauthor and director of Cornell's new vascular center.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Emerging Concepts in CT-Guided Treatment of Coronary Artery Disease
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Related Content
© 2025 MJH Life Sciences

All rights reserved.